Page 15 - School of Medicine and Dentistry | University of Rochester Medical Center
P. 15

From investigator to director of oncology translational
          research to research director, Connie Erickson-Miller
          (pictured below) ’79, ’88M (PhD), has spent almost 20
          years at GlaxoSmithKline. She was the biologist leading
          several pharmaceutical products from creation through
          the development process, with one drug achieving
          regulatory approval in 2008. Another discovery, a
          drug that enhances red blood cell production, is
          currently in clinical trials. Dr. Erickson-Miller recently
          returned to her first love: growing hematopoietic cells
          in the lab, part of a project that aims to identify small
          molecules for the treatment of sickle cell anemia.


          Dr. Erickson-Miller received her B.A. from the
          University, a Ph.D. in microbiology and immunology
          from the School, and she also completed a post-
          doctoral fellowship in pediatric hematology-oncology
          at the Medical Center. “My graduate education
          experience has prepared me to work effectively with
          academic and biotechnology partnerships across
          therapeutic areas to best address patient needs.”
                                                                       Mary Maida (pictured above) ’00M (MS), ’02M (PhD),
                                                                       established the Medingen Group, LLC, and its affiliate,
                                                                       Clerisy Corp., headquartered in Rochester, NY. This
                                                                       research and development incubator specializes in the
                                                                       concept-to-commercialization of products addressing
                                                                       current and emerging health and medical challenges.
                                                                       Her companies move an idea from prototype and
                                                                       licensing to the creation of products for over-the-
                                                                       counter retail environments.


                                                                       Dr. Maida holds a master’s degree in neurobiology and
                                                                       anatomy and a doctorate in molecular neuroscience
                                                                       from the School of Medicine and Dentistry, and still
                                                                       maintains a medical research position at the School.
                                                                       “It’s imperative to have an in-depth comprehension
                                                                       of scientific and clinical issues for which medical
                                                                       technologies and innovations are developed,” she
                                                                       said. “What I learned at the School has played a
                                                                       key role in my successful work in the technology
                                                                       transfer industry.”







                                                                                        The School of Medicine and Dentistry    15
   10   11   12   13   14   15   16   17   18   19   20